Experimental Compounds Show Promise in Repairing Nerve Damage in MS
Researchers have identified two compounds, K102 and K110, capable of repairing the myelin sheath damaged by multiple sclerosis, showing promise for reversing nerve injury and advancing toward human clinical trials.